Hodgkin-limfóma: vizsgálatok itt: Lengyelország
15 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleStudy of MEN1703 in Patients with Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma
- Where
- Bydgoszcz, Cracow, Gdansk, Gdynia, Gliwice, Lublin, Olsztyn, Skorzewo, Torun
- Életkor
- 18 év and over
- People
- 118 worldwide
- Run by
- Ryvu Therapeutics S.A.
See details and how to join2024-513098-31-00 · EU 2024-513098-31-00 - 1/2. fázisTaking peopleA Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
- Where
- Cracow, Gliwice, Katowice, Warsaw
- Életkor
- 18 év and over
- People
- 280 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07519772 · EU 2025-523005-15-00 - 1/2. fázisTaking peopleA Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity of Glofitamab in Monotherapy and in Combination with Chemoimmunotherapy in Pediatric and Young Adult Participants with Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphoma
- Where
- Wroclaw
- Életkor
- Up to 17 év
- People
- 37 worldwide
- Run by
- F. Hoffmann-La Roche AG
See details and how to join2023-504264-41-00 · EU 2023-504264-41-00 - 1. fázisCsak meghívásosA Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
- Where
- Cracow, Gdansk, Katowice, Skorzewo
- Életkor
- 18 év and over
- People
- 120 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06788509 · EU 2024-515457-21-00 - 1. fázisTaking peopleA Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
- Where
- Cracow, Katowice, Skorzewo, Warsaw
- Életkor
- 18 év and over
- People
- 460 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07226843 · EU 2025-523601-16-00 - 1. fázisTaking peopleA Study of ARC-02 in B-cell NHL
- Where
- Cracow, Katowice, Skorzewo, Warsaw
- Életkor
- 18 év and over
- People
- 140 worldwide
- Run by
- Taiho Oncology, Inc.
See details and how to joinNCT07691606 · EU 2026-525606-35-00 - 3. fázisTaking peopleA Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Secondary Antibody Deficiency Associated With Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma
- Where
- Katowice, Kielce, Krakow, Lublin, Skorzewo
- Életkor
- 18 év and over
- People
- 49 worldwide
- Run by
- Grifols Biologicals, LLC
See details and how to joinNCT07582432 · EU 2026-526803-31-00 - 3. fázisTaking peopleA Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma
- Where
- Bydgoszcz, Cracow, Legnica, Olsztyn, Slupsk, Torun, Walbrzych
- Életkor
- 18 év and over
- People
- 386 worldwide
- Run by
- Grifols Therapeutics LLC
See details and how to joinNCT05645107 · EU 2022-502193-16-00 - 3. fázisTaking peopleEfficacy and Tolerability of N-AVD compared to BrECADD in patients with advanced Hodgkin Lymphoma (N-BRAVE)
- Where
- Bielsko-Biała, Cracow, Gdansk, Gliwice, Katowice, Kielce, Krakow, Łódź, Lublin, Olsztyn, Opole, Poznań, Warsaw, Wroclaw
- Életkor
- 18 év and over
- People
- 370
- Run by
- Polska Grupa Badawcza Chloniakow
See details and how to join2026-525263-41-00 · EU 2026-525263-41-00 - No phaseTaking peopleA Study of Brentuximab Vedotin in Adults With Hodgkin's Lymphoma
- Where
- Gdansk, Katowice, Krakow, Lodz, Lublin, Olsztyn, Poznan, Tomaszow Mazowiecki, Warsaw, Wroclaw
- Életkor
- 18 év and over
- People
- 70
- Run by
- Takeda
See details and how to joinNCT05100056 - 3. fázisTaking peopleA trial to learn how effective and safe odronextamab is compared to standard of care for adult participants with previously treated aggressive B-cell Non-Hodgkin Lymphoma.
- Where
- Warsaw
- Életkor
- 18 év and over
- People
- 132 worldwide
- Run by
- Regeneron Pharmaceuticals Inc.
See details and how to joinNCT06230224 · EU 2022-502783-21-00 - 1. fázisTaking peoplePhase I, Open-label, Single-center, Dose Escalation Study to Assess Safety and Tolerability of anti-CD19 CAR-T Cells in Patients with B-cell non-Hodgkin Lymphomas (CARMEN).
- Where
- Wroclaw
- Életkor
- 18 év and over
- People
- 18
- Run by
- Wroclaw Medical University
See details and how to join2024-519318-30-00 · EU 2024-519318-30-00 - 1. fázisTaking peopleStudy of SGR-1505 in Mature B-Cell Neoplasms
- Where
- Gdansk, Lodz, Warsaw
- Életkor
- 18 év and over
- People
- 98 worldwide
- Run by
- Schrödinger, Inc.
See details and how to joinNCT05544019 · EU 2023-505204-34-00 - 2. fázisTaking peopleRadiation-Free Therapy for the Initial treatment of Good prognosis early non-bulky HL, defined by a low Metabolic Tumor Volume and a negative interim PET after 2 chemotherapy cycles- RAFTING
- Where
- Cracow, Gdansk, Gliwice, Olsztyn, Warsaw, Wroclaw
- Életkor
- 18 év and over
- People
- 145 worldwide
- Run by
- Medical University Of Gdansk
See details and how to join2024-515063-66-00 · EU 2024-515063-66-00 - 2. fázisTaking peopleUse of nivolumab (N) followed by chemotherapy: bendamustine, gemcitabine and dexamethasone (BGD) with autologous bone marrow transplantation in patients with Hodgkin’s lymphoma refractory to 1-line therapy.
- Where
- Cracow, Gdansk, Gliwice, Katowice, Lodz, Olsztyn, Warsaw, Wroclaw
- Életkor
- 18 év and over
- People
- 84
- Run by
- Medical University Of Gdansk
See details and how to join2024-515064-31-00 · EU 2024-515064-31-00